Novartis AG (NVSEF)
USD 104.15
(1.66%)
USD 104.15
(1.66%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 46.66 Billion USD | -9.97% |
| 2022 | 51.82 Billion USD | -1.98% |
| 2021 | 52.87 Billion USD | 5.97% |
| 2020 | 49.89 Billion USD | 2.51% |
| 2019 | 48.67 Billion USD | -8.44% |
| 2018 | 53.16 Billion USD | 6.05% |
| 2017 | 50.13 Billion USD | 1.41% |
| 2016 | 49.43 Billion USD | -1.89% |
| 2015 | 50.38 Billion USD | -6.05% |
| 2014 | 53.63 Billion USD | -8.83% |
| 2013 | 58.83 Billion USD | 2.21% |
| 2012 | 57.56 Billion USD | -3.06% |
| 2011 | 59.37 Billion USD | 15.15% |
| 2010 | 51.56 Billion USD | 14.32% |
| 2009 | 45.1 Billion USD | 5.92% |
| 2008 | 42.58 Billion USD | 9.34% |
| 2007 | 38.94 Billion USD | 5.98% |
| 2006 | 36.74 Billion USD | 12.98% |
| 2005 | 32.52 Billion USD | 15.15% |
| 2004 | 28.24 Billion USD | 13.61% |
| 2003 | 24.86 Billion USD | 7.4% |
| 2002 | 23.15 Billion USD | 19.74% |
| 2001 | 19.33 Billion USD | -11.44% |
| 2000 | 21.83 Billion USD | 6.93% |
| 1999 | 20.41 Billion USD | -11.38% |
| 1998 | 23.03 Billion USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 13.17 Billion USD | 4.64% |
| 2024 Q1 | 11.46 Billion USD | -2.64% |
| 2024 Q2 | 12.58 Billion USD | 9.79% |
| 2023 Q3 | 12.09 Billion USD | -13.23% |
| 2023 Q4 | 11.77 Billion USD | -2.61% |
| 2023 FY | 46.66 Billion USD | -9.97% |
| 2023 Q1 | 13.2 Billion USD | 0.92% |
| 2023 Q2 | 13.93 Billion USD | 5.51% |
| 2022 Q3 | 12.84 Billion USD | -1.86% |
| 2022 FY | 51.82 Billion USD | -1.98% |
| 2022 Q4 | 13.08 Billion USD | 1.91% |
| 2022 Q1 | 12.81 Billion USD | -5.24% |
| 2022 Q2 | 13.08 Billion USD | 2.11% |
| 2021 Q4 | 13.52 Billion USD | 1.16% |
| 2021 Q2 | 13.29 Billion USD | 4.73% |
| 2021 FY | 52.87 Billion USD | 5.97% |
| 2021 Q1 | 12.69 Billion USD | -2.58% |
| 2021 Q3 | 13.36 Billion USD | 0.55% |
| 2020 Q1 | 12.7 Billion USD | -0.06% |
| 2020 Q3 | 12.53 Billion USD | 7.88% |
| 2020 Q2 | 11.62 Billion USD | -8.55% |
| 2020 Q4 | 13.03 Billion USD | 3.92% |
| 2020 FY | 49.89 Billion USD | 2.51% |
| 2019 Q4 | 12.71 Billion USD | 1.87% |
| 2019 Q1 | 11.45 Billion USD | -16.17% |
| 2019 Q3 | 12.48 Billion USD | 3.81% |
| 2019 Q2 | 12.02 Billion USD | 4.97% |
| 2019 FY | 48.67 Billion USD | -8.44% |
| 2018 Q4 | 13.66 Billion USD | 20.01% |
| 2018 FY | 53.16 Billion USD | 6.05% |
| 2018 Q2 | 13.45 Billion USD | 4.05% |
| 2018 Q1 | 12.92 Billion USD | -1.79% |
| 2018 Q3 | 11.38 Billion USD | -15.36% |
| 2017 Q2 | 12.49 Billion USD | 6.02% |
| 2017 Q1 | 11.78 Billion USD | -6.51% |
| 2017 Q3 | 12.69 Billion USD | 1.58% |
| 2017 Q4 | 13.16 Billion USD | 3.72% |
| 2017 FY | 50.13 Billion USD | 1.41% |
| 2016 Q4 | 12.6 Billion USD | 2.15% |
| 2016 FY | 49.43 Billion USD | -1.89% |
| 2016 Q1 | 11.81 Billion USD | -7.76% |
| 2016 Q3 | 12.34 Billion USD | -2.67% |
| 2016 Q2 | 12.67 Billion USD | 7.36% |
| 2015 Q2 | 12.89 Billion USD | 5.69% |
| 2015 FY | 50.38 Billion USD | -6.05% |
| 2015 Q4 | 12.8 Billion USD | 2.56% |
| 2015 Q3 | 12.48 Billion USD | -3.19% |
| 2015 Q1 | 12.2 Billion USD | -8.63% |
| 2014 Q4 | 13.35 Billion USD | 0.41% |
| 2014 Q1 | 14.23 Billion USD | -7.32% |
| 2014 FY | 53.63 Billion USD | -8.83% |
| 2014 Q3 | 13.3 Billion USD | -4.65% |
| 2014 Q2 | 13.94 Billion USD | -2.04% |
| 2013 Q3 | 14.55 Billion USD | -0.99% |
| 2013 Q2 | 14.7 Billion USD | 3.51% |
| 2013 FY | 58.83 Billion USD | 2.21% |
| 2013 Q4 | 15.36 Billion USD | 5.53% |
| 2013 Q1 | 14.2 Billion USD | -5.72% |
| 2012 Q1 | 13.91 Billion USD | -7.22% |
| 2012 Q2 | 14.54 Billion USD | 4.51% |
| 2012 Q3 | 14.03 Billion USD | -3.45% |
| 2012 FY | 57.56 Billion USD | -3.06% |
| 2012 Q4 | 15.06 Billion USD | 7.33% |
| 2011 FY | 59.37 Billion USD | 15.15% |
| 2011 Q1 | 14.22 Billion USD | -1.67% |
| 2011 Q2 | 15.12 Billion USD | 6.34% |
| 2011 Q4 | 14.99 Billion USD | -0.25% |
| 2011 Q3 | 15.03 Billion USD | -0.59% |
| 2010 Q1 | 12.35 Billion USD | -6.0% |
| 2010 FY | 51.56 Billion USD | 14.32% |
| 2010 Q4 | 14.46 Billion USD | 12.82% |
| 2010 Q3 | 12.82 Billion USD | 7.54% |
| 2010 Q2 | 11.92 Billion USD | -3.52% |
| 2009 Q3 | 11.29 Billion USD | 5.1% |
| 2009 Q4 | 13.14 Billion USD | 16.43% |
| 2009 Q2 | 10.74 Billion USD | 8.22% |
| 2009 Q1 | 9.92 Billion USD | -4.08% |
| 2009 FY | 45.1 Billion USD | 5.92% |
| 2008 Q2 | 10.72 Billion USD | 4.99% |
| 2008 Q4 | 10.34 Billion USD | -6.18% |
| 2008 Q3 | 11.03 Billion USD | 2.83% |
| 2008 FY | 42.58 Billion USD | 9.34% |
| 2008 Q1 | 10.21 Billion USD | 0.44% |
| 2007 Q4 | 10.17 Billion USD | 3.6% |
| 2007 Q2 | 9.4 Billion USD | -4.26% |
| 2007 Q1 | 9.81 Billion USD | 5.35% |
| 2007 FY | 38.94 Billion USD | 5.98% |
| 2007 Q3 | 9.81 Billion USD | 4.45% |
| 2006 Q3 | 9.69 Billion USD | 5.53% |
| 2006 FY | 36.74 Billion USD | 12.98% |
| 2006 Q4 | 9.31 Billion USD | -3.83% |
| 2006 Q2 | 9.18 Billion USD | 10.61% |
| 2006 Q1 | 8.3 Billion USD | -5.16% |
| 2005 FY | 32.52 Billion USD | 15.15% |
| 2005 Q1 | 7.34 Billion USD | -3.13% |
| 2005 Q2 | 7.87 Billion USD | 7.21% |
| 2005 Q3 | 8.48 Billion USD | 7.87% |
| 2005 Q4 | 8.75 Billion USD | 3.11% |
| 2004 FY | 28.24 Billion USD | 13.61% |
| 2004 Q2 | 6.97 Billion USD | 5.03% |
| 2004 Q3 | 7.05 Billion USD | 1.2% |
| 2004 Q4 | 7.57 Billion USD | 7.38% |
| 2004 Q1 | 6.63 Billion USD | -1.35% |
| 2003 Q1 | 5.72 Billion USD | -26.7% |
| 2003 Q3 | 6.21 Billion USD | 0.11% |
| 2003 Q4 | 6.73 Billion USD | 8.37% |
| 2003 FY | 24.86 Billion USD | 7.4% |
| 2003 Q2 | 6.2 Billion USD | 8.43% |
| 2002 Q4 | 7.8 Billion USD | 54.28% |
| 2002 Q3 | 5.05 Billion USD | -9.63% |
| 2002 Q2 | 5.59 Billion USD | 15.23% |
| 2002 Q1 | 4.85 Billion USD | -5.45% |
| 2002 FY | 23.15 Billion USD | 19.74% |
| 2001 Q1 | 4.44 Billion USD | -25.52% |
| 2001 FY | 19.33 Billion USD | -11.44% |
| 2001 Q4 | 5.13 Billion USD | -7.86% |
| 2001 Q3 | 5.57 Billion USD | 29.34% |
| 2001 Q2 | 4.31 Billion USD | -2.91% |
| 2000 Q2 | 5.8 Billion USD | 1.91% |
| 2000 Q3 | 4.88 Billion USD | -15.93% |
| 2000 Q4 | 5.96 Billion USD | 22.13% |
| 2000 Q1 | 5.69 Billion USD | 0.0% |
| 2000 FY | 21.83 Billion USD | 6.93% |
| 1999 FY | 20.41 Billion USD | -11.38% |
| 1998 FY | 23.03 Billion USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AstraZeneca PLC | 46.91 Billion USD | 0.543% |
| Bristol-Myers Squibb Company PFD CONV 2 | 45 Billion USD | -3.675% |
| CSPC Pharmaceutical Group Limited | 31.45 Billion USD | -48.362% |
| Clarus Therapeutics Holdings, Inc. | 13.95 Million USD | -334212.531% |
| PT Kalbe Farma Tbk. | 1.97 Billion USD | -2257.526% |